SPONSOR
The First Hospital of Jilin University
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Pretreated Pleural MesotheliomaGlioblastomaEpithelial Ovarian CancerAcute Ischemic Stroke
The First Hospital of Jilin University is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Pretreated Pleural Mesothelioma, Glioblastoma, Epithelial Ovarian Cancer, Acute Ischemic Stroke.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The First Hospital of Jilin University
How many clinical trials has The First Hospital of Jilin University sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by The First Hospital of Jilin University, of which 4 are actively recruiting participants. These trials cover conditions including Pretreated Pleural Mesothelioma, Glioblastoma, Epithelial Ovarian Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The First Hospital of Jilin University research focus on?
The First Hospital of Jilin University clinical trials span Pretreated Pleural Mesothelioma, Glioblastoma, Epithelial Ovarian Cancer, Acute Ischemic Stroke. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The First Hospital of Jilin University clinical trial?
To participate in a The First Hospital of Jilin University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The First Hospital of Jilin University trials with current recruitment status updated daily.
Clinical Trials by The First Hospital of Jilin University
NCT06875076 Phase 2
Recruiting
Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
Pretreated Pleural Mesothelioma
NCT06740955
Recruiting
Hypofractionated Radiotherapy
Glioblastoma
NCT07495397
Recruiting
Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)
Epithelial Ovarian Cancer
NCT06045156
Recruiting
Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke
Acute Ischemic Stroke
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology